1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CELLECTIS - ADR
Cellectis - ADR XNAS: CLLS

Cellectis - ADR Live Stock Price Today, Share Analysis and Chart

Expensive Rocket
about

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the fi...

Read More
2.62 -0.05 (-1.87%)
New 52W High in past week
34,660
XNAS Volume

XNAS 31 Jul, 2025 1:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Cellectis - ADR is on 06 Aug 2025 for the purpose of Cellectis SA Second Quarter Earnings Results for 2025 See details
Durability score
Medium Financial Strength
38.9 / 100
Valuation Score
Expensive Valuation
25.7 / 100
Momentum Score
Technically Bullish
75.8 / 100
Expensive Rocket These stocks are a favourite among investors due to their bullish nature, good technical aspects but they have bad valuation and medium financials. View Similar Embed DVM
Analyst Price Target
6
1Yr Price target upside is 119%
4 analysts

17

S

6

W

2

O

2

T

SWOT Analysis

Cellectis - ADR Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..